Technology News and Research

RSS

Simple soft-drink cooler could help patients battle antibiotic-resistant TB

Tuberculosis, now largely controlled in the industrialized world, remains a stubbornly persistent killer in most of Africa, as well as parts of Asia and South America. The spread of multidrug-resistant strains of TB has slowed progress against the devastating disease, which is estimated to strike more than 10 million people annually. Now a modified soft-drink cooler, developed by researchers at MIT's D-Lab, could make a dent in the disease's impact.

31 May 2012

Data from Response Genetics' tests against cancer to be presented at ASCO 2012

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today four presentations to be held during the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 1 to June 5, 2012. Study results are based on the company's proprietary technology and approach.

31 May 2012

Kona Medical raises $30 million in Series C financing

Kona Medical, Inc. today announced it has raised $30 million in Series C financing to advance its novel hypertension therapy.

31 May 2012

Foundation Medicine introduces first pan-cancer genomic profile

Foundation Medicine announced today the commercial launch of FoundationOne, the first pan-cancer, fully informative genomic profile designed to help oncologists expand their patients' treatment options.

31 May 2012

Interim data from UCLA and NeuroSigma’s eTNS Phase I trial on PTSD, MDD

Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.

31 May 2012

BHD launches Statin Induced Myopathy Genotype test

Boston Heart Diagnostics (BHD) announced today the commercial launch of the Statin Induced Myopathy (SLCO1B1) Genotype test licensed from the University of Oxford's technology commercialization company Isis Innovation.

31 May 2012

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.

31 May 2012

AAPS honors Morphotek with 2012 Excellence in Ligand Binding Assays Award

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, "Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies."

31 May 2012

Pfizer’s XALKORI now available in Canada

Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).

31 May 2012

Cohera Medical receives U.S. patent titled, ‘Hydrophilic Biodegradable Adhesives’

Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,182,647, titled "Hydrophilic Biodegradable Adhesives".

31 May 2012

U.S. FDA clears INJEX Pharma’s needle free injection system

The FDA had registered INJEX Pharma GmbH, Berlin, and INJEX Pharma US, Miami, and given approval for the import and sale of INJEX 30 in the US market. The condition was the registration by the FDA for INJEX Pharma GmbH as manufacturer and exporter.

31 May 2012

International conference: 'Preventing Overdiagnosis'

Overdiagnosis poses a significant threat to human health by labeling healthy people as sick and wasting resources on unnecessary care, warns Ray Moynihan, Senior Research Fellow at Bond University in Australia, in a feature published on bmj.com today.

31 May 2012

AssureRx closes $12.5M Series C financing

AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.

31 May 2012

USAID announces Food Security Open Data Challenge

Following President Barack Obama's announcement of the New Alliance for Food Security and Nutrition at a food security summit last week, "USAID launched a Food Security Open Data Challenge that invites technologists, agriculture stakeholders, entrepreneurs, academics, and others to determine the most creative and wide-reaching use of open data for food security solutions and better, cheaper, and faster results," Maura O'Neill, chief innovation officer at USAID, and Kat Townsend, special assistant for engagement at USAID, write in a post in the agency's "DipNote" blog (5/27).

30 May 2012

New technique promotes dramatic increase in cardiac function

LoneStar Heart Inc., today announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart muscle cells to treat damage following a heart attack and other forms of heart disease.

30 May 2012

FDA clears Teleflex’s Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter

Teleflex Incorporated announced today the Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

30 May 2012

Beike stem cell bank in China granted AABB accreditation

Beike Biotechnology Co., Ltd announced that it has been awarded AABB accreditation for cord blood and cord tissue banking. This accreditation has been granted following an intensive on-site assessment by AABB assessors and establishes that the level of medical, technical and administrative performance within the facility is in accordance with the AABB standards or exceeds those set by AABB.

30 May 2012

Breathe Technologies earns Medical Design Excellence Award for NIOV System

Breathe Technologies, Inc. today announced that their Non-Invasive Open Ventilation (NIOV) System has been awarded a prestigious Medical Design Excellence Award (MDEA).

30 May 2012

MAQUET to acquire Avalon Elite Bi-Caval Dual Lumen Catheter, complimentary vascular access kits

MAQUET Cardiopulmonary, a business unit of MAQUET Cardiovascular and a leader in extracorporeal life support (ECLS) systems, today announced that they have signed an agreement with Avalon Laboratories to acquire its Avalon Elite Bi-Caval Dual Lumen Catheter and complimentary vascular access kits for use during ECLS.

30 May 2012

QCMG establishes Illumina technology as core sequencing platform

Illumina today announced that the Queensland Centre for Medical Genomics (QCMG), home of Australia's International Cancer Genomics Consortium program, has established Illumina technology as its core sequencing platform in an expanded facility.

30 May 2012